Can Rife Therapy Help Stop Ebola?

As the world watches with increasing horror the slow but sure spread of Ebola virus disease, health authorities are struggling with how best to treat the afflicted while maintaining strict isolation and quarantine.

Distressingly many healthcare workers taking care of ill patients have themselves been infected and are in mortal danger, including Americans Dr. Kent Brantly and Nancy Whitebol.

The disease is highly infectious, meaning once a patient comes in contact with the virus, a severe illness almost always develops. Patient commonly develop fatal hemorrhages from their mouths, eyes, and skin.

ebola Can Rife Therapy Help Stop Ebola?

Ebola virus


There is no vaccine for Ebola currently and no specific cure or antidote other than supportive care such as intravenous fluids, oxygen, blood transfusions and correcting electrolyte abnormalities

News organizations today are reporting the importation of an untried experimental serum to try to halt or reverse the course of the disease, with health authorities no doubt willing to risk any unknown adverse side effects against a hoped for, life-saving benefit.

However, sadly there was apparently only enough medicine for one dose, which Dr. Brantly gallantly gave to Ms. Whitebol. As of this writing, both Americans remain in guarded condition.

In this clearly desperate scenario for those currently infected and for the worldwide health ramifications, would it be wise to ask what other unproven experimental treatments could be employed as a last gasp strategy to try to save lives when there is nothing left to do?

One possibility that might bear consideration is Rife therapy – a controversial treatment modality that has been largely discredited by medical authorities in the United States as unproven.

Although considered little better than quackery by much of the American medical establishment, Rife therapy is a more widely accepted therapeutic modality in Europe and is used for a wide variety of conditions, including cancer and other serious illness.

Rife therapy machines come in many styles and models. For illustration purposes, one popular and commonly used machine sold in Canada is described as a photon resonant light emission device (dubbed the PERL.)

The device (about the size of a small suitcase) is a non-contact, non-invasive device that uses electricity to stimulate argon gas in a closed tube to emit an electrostatic charge, light, and an electromagnetic frequency (EMF.)

When the device is turned on it delivers radio frequencies in a 360 degree pattern. Literature from the manufacturers states that the resultant EMF can be used for the control of microbes, including viruses, bacteria, fungi, and yeast**.

The manufacturer states in the instruction manual that the anti-microbe EMFs travel up to 30 feet and will penetrate walls, concrete, steel, and lead.

The device is easily programmable to deliver the specific frequencies desired. There are published protocols widely available on the Internet on specific frequency protocols that purportedly are effective for different classes of microbes being targeted.

Almost all state medical boards in the United States strongly discourage physician participation or recommendation of Rife treatment. Penalties for prescribing Rife treatment can include censure and loss of licensure.

Despite this official condemnation, Rife therapy is quietly used by tens of thousands of patients in the United States for a wide range of ills, including most commonly as an antimicrobial strategy for Lyme disease. Many of these patients give positive anecdotal reports of efficacy in controlling their infections.

Not surprisingly, due to antipathy of the medical establishment most physicians avoid professional consideration of Rife therapy and there are few recent studies investigating Rife therapy in humans.

However, there has been some research in the past 20 years published in animal and in vitro models that has investigated the use of electromagnetic frequencies as a strategy and shown a positive effect in controlling microbial infection and producing beneficial changes on wound healing, immune response, and inflammatory response.

In a study investigating the use of electromagnetic fields to control the protozoan infection coccidiosis in broiler chickens, it was found that exposure had an antagonistic effect on the causative Eimeria organisms treated birds (Elmusharaf and Cuppen, 2007.)

There are also suggestions that the use of electromagnetic fields may cause an anti-inflammatory effect and promote wound healing in rats (Jasti and Wetzel, 2001.)

In addition, several studies have suggested in vitro anti-inflammatory effects of electromagnetic frequency treatment ( Cronstein and Montesinos, 1999; Valbona and Richard, 1999; Montesionos and Yap, 2000.)

EMF exposure has also been shown to effect a heightened immune response in several in vitro studies (Blank and Khorkova, 1992; Goodman and Blank, 1994; Simco and Mattsson, 2004.)

This EMF mediation of inhanced immunity has also been suggested in a rat model (Mevissen and Haussler, 1998.)

So, how could Rife therapy actually be employed in a treatment facility caring for Ebola patients?

ebola hand1 Can Rife Therapy Help Stop Ebola?

Ebola infection affecting the hand

One scenario could have the Rife machine set up outside of the isolation tent to avoid contaminating the equipment. The unit and the control pad could be wrapped in clear plastic as an added precaution without affecting the performance or treatment effect.
The desired frequencies could then be programmed and the unit turned on.

The patients to be treated would remain in their hospital beds or perhaps moved to within 6-12 feet of the device for optimal effect while still remaining on the isolation side of the structure. Depending on the size of the isolation room, multiple patients could be treated simultaneously.

The timing and duration of the treatment sessions could be tailored based on clinical response but initially could be patterned off one of the many published protocols used by patients ill with other serious infections.

But, in the end, the harsh, horrible truth is that there is no more serious and deadly than infection with Ebola. In the not too distant future, likely spurred on by this outbreak, scientists will design and mass produce a vaccine to spare the world this scourge.

But, sadly, that welcome development will come too late for those that are ill and dying today. Do we as physicians, health care providers, and fellow human beings owe it to those afflicted to at least be open and willing to try another unproven and untested treatment that might get them to the other side of this terrible disease.

They are counting on us.


* The manufacture includes a disclaimer in their sales literature that the PERL is not intended as a medical device.

Luray – #1

I did only the caverns. I drove down Interstate 81 and turned off the highway for the 15 mile drive to Luray. The signs are clearly marked and the entrance to the caverns is covered by a rather ugly spanish style pavilion. It was a Sunday and the parking lot was crowded – lots of Japanese tour buses.

The admission fee is $19 for adults. You assemble in the waiting area and they let groups in every 5 minutes or so. There are no guided tours really. You walk along the pathways and every little bit there is a “guide” but they don’t really give a spiel.

The walking tour takes about an hour and the vertical descent is 165 feet so it is a fairly easy walk for caverns. There has been quite a bit of “development” in the cave so the walkways are wide and there are handrails. Unfortunately, to do this it looks as if there has been some damage down in terms of knocking down formations.

About 15 minutes into walk there is a reflecting pool that is interesting, there is the requisite wishing well, and then towards the end there is a small formation called the fried eggs that you should look for. You exit the cave into the gift shop, but the clerk mentioned that there is nothing for sale that is actually from the cavern itself.

Rating B-

Copyright 2007

Valerie Arkoosh, MD – Candidate for Congress (Part 3 of 3)

Valerie Arkoosh, MD, is a former Chair of Anesthesiology, a health policy expert, and a candidate for Congress running in the Democratic primary in the 13th Pennsylvania district. We recently had time to speak to Dr. Arkoosh about her career as a physician and what she hopes to accomplish if elected to Congress.

Val Headshot 2 2 Valerie Arkoosh, MD   Candidate for Congress (Part 3 of 3)

Dr. Valerie Arkoosh

What are the most important skills you learned as a Chair that will help you if you are elected to Congress?

As an anesthesiologist you learn very early how to always appear calm!

But, really, I think the skills of bringing people together who often have very different viewpoints about what needs to happen next.

And, getting people to sit down and talk and getting agreement on what’s in the best interests of our mission and really keeping people focused on the most important thing.

I really honed those skills and, frankly, I think those skills will be really incredibly useful in congress

If you are elected to Congress what will be your first priority legislatively?

Number one on my list is raising minimum wage.

If we haven’t already raised the minimum wage by then that would certainly be one of the first pieces of legislation that I would like to get involved with.

We have 35,000 families …. in the 13th living at poverty level or below. Two thirds of minimum wage workers are women and this is really an issue that needs addressing and quickly. Some states have already raised the minimum wage

Right now, Pennsylvania uses the federal minimum wage which is $7.25/hr. The president has proposed raising that to $10.10 and that just happens to coincide with what’s considered a living wage here in the Philadelphia area for a single adult.

A living wage takes into account what it costs to buy food, rent, those sorts of things in any community. What is difficult is that if you look at what it costs for an adult with one child here in the Philadelphia area that living wage jumps to almost $20/hr.

So, we are not going to have a minimum wage in that range obviously. But, I think what has to go hand and glove with that number is also making sure that people have access to affordable child care, that they have paid family medical leave, some of these other pieces that can make that living wage not so difficult to achieve .

Do you support the proposed increase to the $10 figure supported by the President?

I would much prefer it to be closer to $12. I think here in the Philadelphia area that gets us in a much better position for more people.

What is one little known fun fact about you?

I just love to eat candy. I’m like a little kid with candy. I have a real sweet tooth.

Disclosure – the interviewer is a long-time colleague and admirer and supporter of Dr. Arkoosh’s endeavors, starting with jointly performed liver transplants many years ago up to the current campaign for Congress.

Boston ER Physician Loses Malpractice Suit Over Rare Condition

A Boston physician has been successfully sued in a malpractice case after missing a rare diagnosis for an untreatable condition in the emergency room. The judgement against Dr.Liang was for $4.8 million after he failed to miss a case of viral myocarditis in a 23 year old man.

Legionella Found at UPMC Presbyterian

Officials at the University of Pittsburgh Medical Center Presbyterian Hospital have disclosed that Legionella bacteria in the hospitals ice machines have killed one patient and sickened two others.

Valerie Arkoosh, MD – Candidate for Congress (Part 2 of 3)

Dr. Val Arkoosh is an Anesthesiologist by training and a current candidate for Congress in the Pennsylvania 13th Congressional District. We recently had the chance to speak to Dr. Val to get her thoughts on being a doctor and being a candidate.

Why did you decide to leave full time clinical practice at Jefferson and go to into administration?

The position I left Jefferson to take was a pretty exciting one.

You might remember that Allegheny opened this hospital for women. It was PCOM’s old hospital on City Ave.

And they opened it up and reconfigured I to be a hospital for women. So they moved all the OB GYN, gyn onc ,breast surgery, most women’s services from Hahmemann and Medical College of Pennsylvania to that new hospital for women on City Ave. So that was actually the position that I left for.

Val OR 1024x682 Valerie Arkoosh, MD   Candidate for Congress (Part 2 of 3)

Anesthesiologist Valerie Arkoosh, MD

Looking back were you satisfied with your new position?

That was just a really great opportunity for me to really focus on women’s health as well as take on additional leadership and administrative responsibilities in the department.

How soon after you took your position did the hospital close?

After I had been there for 18 months, so I had really exqusite timing.

After the closing what did you do?

It was about 6 months after the system came out of bankruptcy in the spring of 1999 that I took over as Chair of the entire department of Hahnemann and MCP. I had academic responsibility for St Christopher’s as well, although I didn’t have budgetary authority at St Chris.

Why did you decide to stay in a health system that was so troubled financially?

Number one, I was very committed to the faculty I had recruited and the programs I was involved in bu ilding and that we had worked on in that hospital for women. I didn’t want to abandon people.

I also thought it was a really interesting opportunity to be in the midst of a system that was emerging from bankruptcy. I was actually able to draw on my economic background quiet extensively.

And, I was very curious to see how the partnership between the medical school which at that point was under the umbrella of Drexel – how that relationship would work with Tenet, which was the for profit owner of the hospitals coming out of bankruptcy.

Why did you end up resigning and leaving the Drexel system in the summer of 2004?

Two things happened.

When you are Chair in a troubled system and challenged system you get a very deep understanding of some of the problems in our healthcare system kinda writ large.

And at the same time my patients …. were just falling through the cracks in our community – lack of a job that paid a living wage, poor educational opportunities, and private health insurance companies that routinely discriminated against women with preexisting conditions.

I decided that I wanted to have a better understanding of the policy side if the equation. So, I stepped down so I could go back to school.

I went over to Penn in a part time clinical position with part time clinical duties so I could start school, which I did at Johns Hopkins in 2005 to get my Masters in Public Health. And, I focused on US health policy in that master’s training.

What would you say was your biggest area of growth during your two Chair jobs at Drexel?

The most important thing was learning how to both manage and lead – and they are two different skills in some ways – during very complicated and uncertain times.

We had weeks during the bankruptcy where we did not know if hospital doors were going to be locked when we came in the morning.

There was a day at City Avenue hospital where we were doing about 12-15 deliveries a day at that point and we only had 10 epidural trays left in the hospital. So, you are realizing that you may not have adequate supplies to take care of your patients.

It was a pretty tumultuous time and I really learned so much from that.

Disclosure – the interviewer is a former colleague and longtime supporter and admirer of Dr. Arkoosh’s endeavors, starting with the many liver transplants done jointly in the middle of the night up to her current Congressional campaign.

Valerie Arkoosh, MD – Candidate for Congress (Part 1 of 3)

Valerie Arkoosh, MD, is an Anesthesiologist, past President of the National Physicians Alliance, and a candidate for Congress running in Pennsylvania’s 13th Congressional district, located in Northeast Philadelphia and Montgomery County. We recently spoke to Dr. Arkoosh about her roles as a physician and health policy expert.

Where were you born and raised?

I was born and raised in Omaha, Nebraska.

Where did you go to college and what was your major?

Northwestern University and I got a BA in Economics.

Continue reading "Valerie Arkoosh, MD – Candidate for Congress (Part 1 of 3)">

UK Scientists Close To Implanting Lab Grown Nose

UK Scientists are close to implanting lab grown nose, according to lead researcher Alexander Seifalian of University College London. The lab has also grown artificial tracheas and blood vessels from stem cells and is working on mass-producing ears, which are considered technically more difficult to produce.

Drs. Michelle Griffin and Suchitra Sumitran-Holersson of the University of Gothenburg comment.

Morcellation of Fibroids To Be Eliminated by Boston Hospitals

Morcellation of fibroids is commonly done during laparoscopic hysterectomy to aid in removal of a large amount of tissue through a small surgical port in the abdomen.

Unfortunately, this procedure has recently been implicated in the development of widespread intra-abdominal cancer in two women recently in Boston. In response, Massachusetts General Hospital and Brigham and Women’s Hospital in Boston are banning the procedure in fibroid removal surgeries.

Dr. Amy Reed is one patient who is now battling stage IV cancer after the procedure spread leiomyosarcoma cells contained within a fibroid throughout her abdomen.

There has been an error.

We apologize for any inconvenience, please return to the home page or use the search form below.